AI assistant
Sending…
REVVITY, INC. — Director's Dealing 2013
May 2, 2013
30616_dirs_2013-05-02_9e4ca5cb-2233-48a2-a996-4c6d30adde42.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PERKINELMER INC (PKI)
CIK: 0000031791
Period of Report: 2013-04-30
Reporting Person: MICHAS ALEXIS P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-04-30 | Common Stock | A | 3263 | — | Acquired | 114996 | Direct |
| 2013-05-01 | Common Stock | M | 6440 | $21.670 | Acquired | 121436 | Direct |
| 2013-05-01 | Common Stock | S | 6440 | $30.845 | Disposed | 114996 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-04-30 | NQ Stock Option (right to buy) | $30.510 | A | 5601 | Acquired | 2020-04-30 | Common Stock (5601) | Direct |
| 2013-05-01 | NQ Stock Option (right to buy) | $21.670 | M | 6440 | Disposed | 2013-05-02 | Common Stock (6440) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 500 | Indirect |
Footnotes
F1: Includes shares related to dividends on shares in the Deferred Compensation Plan in the Reporting Person's account.
F2: This option vests in three equal annual installments beginning on the first anniversary of the date of grant, and has a 7 year exercise term.
F3: This option became exercisable in three equal annual installments beginning on May 2, 2007, which was the first anniversary of the date on which the option was granted.
More from REVVITY, INC.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 16
Proxy Solicitation & Information Statement
2026
Mar 16
Proxy Solicitation & Information Statement
2026
Mar 16
Regulatory Filings
2026
Mar 6
Director's Dealing
2026
Feb 26